Abstract Topics
Late Breaking Abstract Submission is open
November 28, 2022 – January 23, 2023 23:59 EDT.
Submit Abstract
Basic Science
- Taxonomy
- Animal Models and Papillomaviruses
- Immunology
- Regulation of Gene Expression, Post-transcriptional Modification
- Transformation and Carcinogenesis
- Structural Biology
- Virus – Host Interactions
- Virus Life Cycle
- Genomics of HPV-Associated Disease
- Papillomavirus Vaccines (i.e New Developments)
- Beta and Gamma Cutaneous HPV Infection, Biology, and Natural History
- Microbiome
- Other Basic Research
Clinical Research
- Self-Sampling and the Other New Technologies for Cervical Screening
- HPV Diagnostics and Biomarkers for Early Detection and Management of Cervical Cancer and Related Precursors
- Diagnosis and Management of HPV-Related Anogenital Cancers Other Than Cervix: Penile, Vaginal, Vulvar and Urological Cancer and Related Precursors
- Behavioral Science Aspects of New Technologies in Cervical Screening Including Dissemination/Communication Research
- Diagnosis and Management of Anal Cancer and Related Precursors: Screening, Diagnosis and Management
- Diagnosis and Management of HPV-Related Oropharyngeal, Head and Neck Cancer
- Diagnosis and Management of Genital and Cutaneous Warts
- Diagnosis and Management of Cutaneous Warts and Other Skin Lesions
- Prophylactic Vaccines – Clinical Aspects
- Therapeutic Vaccines – Clinical Aspects
- Diagnosis and Management of HPV Disease in People Living with HIV and Other Forms of Immunocompromise
- Screening, Diagnosis and Treatment of Cervical Precancer in Low-Resource Settings
- Novel Therapeutic Approaches to Treatment of HPV-Related Disease Including Antivirals
- Novel Diagnostic Technologies for HPV-Related Disease
- Recurrent Respiratory Papillomatosis
- HPV NAAT Screening Quality Control/Assurance Guidelines
- Other Clinical Research
Public Health, Epidemiology and Implementation Science
- Global Impact of HPV and Cervical Cancer Prevention
- Epidemiology: Natural History/Risk Factors (Cervix)
- Epidemiology: Natural History/Risk Factors (Anal)
- Screening for HPV-Related Disease: Implementation, Evaluation and Impact
- Vaccination: Implementation, Evaluation and Impact
- Economics and Mathematical Modelling
- Cervical Cancer Elimination
- Vaccine Safety
- Impacts of COVID-19 Pandemic on HPV Vaccination Implementation
- Impacts of COVID-19 Pandemic on Public Health Aspects of HPV Screening
- Other Public Health, Epidemiology and Implementation Science Research